menu
Pediatric Neurologist, Epileptologist
Neuroscience
Ki Hyeong Lee, MD, MS, is a board-certified neurologist and epileptologist with AdventHealth Medical Group and the Medical Director of AdventHealth for Children’s pediatric epilepsy center in Orlando. A leading provider of diagnostic and surgical techniques for addressing epilepsy and seizures, Dr. Lee completed three prestigious fellowships in clinical neurophysiology, epilepsy research and stroke at the Medical College of Georgia, Mayo Clinic Foundation in Minneapolis and Seoul National University Hospital in Korea, respectively. A noted researcher who regularly presents his work in published articles and international medical forums, he constantly seeks to advance the state of epilepsy patient care through medical breakthroughs and new technologies.
FRONTIERS IN NEUROSCIENCE
2020
NEUROSURGICAL FOCUS
2020
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY
2019
BMC NEUROLOGY
2017
JOURNAL OF NEUROSURGERY-PEDIATRICS
2017
JOURNAL OF PEDIATRIC EPILEPSY
2015
JOURNAL OF PEDIATRIC EPILEPSY
2014
JOURNAL OF NEUROSURGERY-PEDIATRICS
2014
Seoul National University College of Medicine
Medical College of Georgia
Pediatric Neurology
American Board of Psychiatry and Neurology
This study is currently enrolling.
This is a randomized, double-blind, placebo-controlled trial, designed to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to subjects in SRSE.
The reason for this study is to evaluate natalizumab as an adjunctive therapy in adults with drug-resistant focal epilepsy. As with any medicine, some people taking study drug may respond well while others may not respond ...
The main purpose of this study is to learn if and how well the study drug works and if the study drug is safe and tolerable compared to placebo in children and adults with Lennox-Gastaut syndrome. A placebo is an inactive ...
This study is currently enrolling.
Through a chart review of children with antibodymediated autoimmune encephalitides we aim to describe: a) extent and type of neurologic manifestations at presentation, hospitalization (s), and follow up. b) improvement or ...